Carson Wealth (CWM LLC)
RAPT

Carson Wealth (CWM LLC)’s RAPT Therapeutics RAPT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32
Closed -$1K – 5774
2025
Q4 		$1K Sell
32
-81
-72% -$2.52K ﹤0.01% 5269
2025
Q3 		$3K Sell
113
-589
-84% -$7.71K ﹤0.01% 4930
2025
Q2 		$6K Sell
702
-1,106
-61% -$8.44K ﹤0.01% 4558
2025
Q1 		$18K Buy
1,808
+1,577
+683% +$15.5K ﹤0.01% 3765
2024
Q4 		$3K Buy
231
+171
+285% +$2.17K ﹤0.01% 4447
2024
Q3 		$1K Sell
60
-38
-39% -$769 ﹤0.01% 4683
2024
Q2 		$2K Buy
98
+90
+1,125% +$4.16K ﹤0.01% 4257
2024
Q1 		$1K Buy
8
+5
+167% +$695 ﹤0.01% 4198
2023
Q4 		$1K Buy
+3
New +$371 ﹤0.01% 4024
2023
Q2 		– Sell
-3
Closed – – 4415
2023
Q1 		$0 Buy
+3
New +$607 ﹤0.01% 4291

Carson Wealth (CWM LLC)'s RAPT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 32 shares — an estimated $1K sold.

Carson Wealth (CWM LLC) first reported a position in RAPT in Q1 2023 and held it in 10 quarters. The position peaked at $18K in Q1 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

  • Carson Wealth (CWM LLC) reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 32 RAPT Therapeutics shares in Q1 2026, an estimated $1K.
  • Carson Wealth (CWM LLC) first reported a position in RAPT Therapeutics in Q1 2023 and held it in 10 quarters.
  • Carson Wealth (CWM LLC)'s RAPT Therapeutics position peaked at $18K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.